BioSante Pharmaceuticals, Inc. (BPAX)

[dgras0007]

Gents - The fundamentals do not change. Bpax is set for a Feb 14 date, Libigel is not dead, the company is sitting in a lot of cash, has a strong cancer vaccine pipeline and - as stated by its CEO- it's looking for suitable acquisitions - that is without considering Bpax as a company is a potential acquisition at a multiple all and in itself. So - obviously there is an agenda in motion. If anything, this is about turning this into a re-entry buying opportunity. I sold 75% of my position yesterday including a substantial amount of calls. Always take profits. But this - allows me to re-entry.

@ the moderator: can you not limit my posts to one a day. Thanks.